Number needed to treat to gain one controlled hypertensive José R. BanegasFernando Rodriguez-ArtalejoPilar Guallar-Castilløn Invited Commentary Pages: 75 - 76
Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus Dierk H. EndemannErnesto L. Schiffrin OriginalPaper Pages: 85 - 89
Hypertension in diabetes: The role of the vasculature Naftali SternYonit Marcus OriginalPaper Pages: 90 - 97
The tissue renin-angiotensin-aldosterone system in diabetes mellitus Donna S. HanesAnita NaharMatthew R. Weir OriginalPaper Pages: 98 - 105
Metabolic issues in the antihypertensive and lipid-lowering heart attack trial study Henry A. PunziConnie F. PunziTrinity Hypertension Research Institute OriginalPaper Pages: 106 - 110
Vascular angiotensin II actions mediated by angiotensin II type 2 receptors Ruth E. HannanRobert E. Widdop OriginalPaper Pages: 117 - 123
Newly recognized physiologic and pathophysiologic actions of the angiotensin-converting enzyme Sebastien FuchsKristen FrenzelKenneth E. Bernstein OriginalPaper Pages: 124 - 128
Renin/prorenin-receptor biochemistry and functional significance Geneviève NguyenCéline A. BurckléJean-Daniel Sraer OriginalPaper Pages: 129 - 132
Nephron endowment and blood pressure: What do we really know? Michelle M. KettJohn F. Bertram OriginalPaper Pages: 133 - 139
Improved blood pressure control with nocturnal hemodialysis: Review of clinical observations and physiologic mechanisms Brendan B. McCormickChristopher T. Chan ReviewPaper Pages: 140 - 144
Hypertensive renal damage: Insights from animal models and clinical relevance Karen A. GriffinAnil K. Bidani OriginalPaper Pages: 145 - 153